This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
A Case-Based Approach to OAB

A Case-Based Approach to OAB

Format

Webcast

Time to Complete

30 minutes

Released

June 25, 2019

Expires

June 24, 2020
Add to Queue


Maximum Credits

0.50 / AMA PRA Category 1 Credit(s)TM
0.50 / CNE Contact Hours

Accredited Provider

This educational activity is jointly provided by the Society of Urologic Nurses and Associates (SUNA) and Haymarket Medical Education.

Commercial Supporter

Supported by an educational grant from Astellas

Program Description

Overactive bladder (OAB) is commonly seen throughout the world and has a signficant burden on the lives of affected individuals. Successful clinical outcomes and patient satisfaction are dependent on timely identification of symptoms, appropriate evaluation, effective communication and patient education, and realistic treatment plans and goals. For optimal results, approaches to OAB management should be tailored to the characteristics, comorbidities, and needs of each patient. At the present time, diagnostic lags are common among patients with OAB, and patient dissatisfaction with traditional therapies is high.

In this virtual roundtable, an expert faculty panel discuss care decisions for 3 different patients with OAB. The faculty will discuss optimal treatment approaches for each featured patient, focusing on the need to consider the unique needs and preferences of each individual when making therapeutic decisions.

Intended Audience

This activity is designed for an international audience of urologists, ob-gyns and primary care (general medicine, internal medicine, family medicine) MDs, DOs, PAs, NPs and RNs.

Educational Objectives

Learning Outcome
After completing these learning activities, the learner will be able to apply evidence-based strategies to appropriately identify and manage care of patients with OAB.

Learning Objectives
  • Routinely initiate conversations about urinary health with patients
  • Counsel individuals with symptoms consistent with OAB about potentially useful behavioral and pharmacologic interventions
  • Implement combination therapy for appropriate patients with OAB who are refractory to traditional therapy

Accredited Provider Disclosure of Conflicts of Interest Statement

In accordance with the ACCME’s Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 12 months. HME and SUNA implement a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners. The relevant financial relationships of those persons in a position to control the content of this CME/CNE activity will be disclosed prior to the start of the educational activity.

This CME/CNE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CNE activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.

Faculty

Paul Doghramji, MD, FAAFP
Medical Director of Health Services
Ursinus College
Collegeville, PA

Dr. Doghramji has no relevant financial relationships to disclose.

David Ginsberg, MD
Clinical Professor of Urology
USC-Keck School of Medicine
Los Angeles, CA

Dr. Ginsberg is on the speakers’ bureau for Avadel Pharmaceuticals and received funds from Bioness.

Masayuki Takeda, MD, PhD
Exective Director/Vice President
Director, University Hospital
Professor and Chairman
Department of Urology
University of Yamanashi
Graduate School of Medical Sciences
Yamanashi, Japan

Dr. Takeda has no relevant financial relationships to disclose.

Accredited Provider Disclosure

Haymarket Medical Education staff involved in the planning and content review of this activity have no relevant financial relationships to disclose.

The Society of Urologic Nurses and Associates staff involved in the planning and content review of this activity have no relevant financial relationships to disclose.

Credit

0.50

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

Haymarket Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

HME designates this enduring activity for a maximum of 0.50 hours of AMA PRA Category 1 CreditTM.

European physicians can submit and apply the AMA certificate of credit to their European-based CE or continuing professional development (CPD).

Credit

0.50

Type

CNE Contact Hour(s)

Accreditation Statement

The Society of Urologic Nurses and Associates is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

SUNA is a provider approved by the California Board of Registered Nursing, provider number CEP 5556.

Designation Statement

SUNA designates this enduring activity for a maximum of 0.50 contact hours for nurses.

Additional Credit Information

Physician Assistant Continuing Education
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM   from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 0.50 Category 1 Credit for completing this activity.

Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for education activities certified for AMA PRA Category 1 CreditTM   from organizations accredited by ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.

Disclosure of Unlabeled Use

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.

Disclaimer

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of HME, SUNA, or Astellas. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Method of Participation/Instructions

Default instructions: To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCMETM within your Profile/CME History, which you can access at any time.

Privacy Policy

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue


Related to this activity